Rapport: "Embryonale stamceller". - Teknologirådet

More documents

Recommendations

Info

<strong>Embryonale</strong> stamceller – høring om anvendelse af stamceller i forskning og behandling 23. januar 2003 JESPER NORUS, INSTITUTLEDER, LEKTOR, COPENHAGEN BUSINESS SCHOOL: ......................................................................68 DE SUNDHEDSMÆSSIGE PERSPEKTIVER.................................................................................................................77 OLE FÆRGEMAN, PROFESSOR, DR.MED., DEN CENTRALE VIDENSKABSETISKE KOMITÉ, ÅRHUS UNIVERSITETSHOSPITAL:.......77 JENS-OTTO S. JEPPESEN, OMRÅDEDIREKTØR, ODENSE UNIVERSITETSHOSPITAL:.................................................................79 DE SAMFUNDSMÆSSIGE RAMMER..........................................................................................................................89 OLE HARTLING, OVERLÆGE, DR.MED., FORMAND FOR DET ETISKE RÅD FRA 2003:.............................................................89 PETER ØHRSTRØM, PROFESSOR, DR. SCIENT., MEDLEM AF DET ETISKE RÅD: .......................................................................90 LENE KOCH, LEKTOR, DR. PHIL., INSTITUT FOR FOLKESUNDHEDSVIDENSKAB, KØBENHAVN UNIVERSITET: ...........................91 LARS WAHLBERG, DIREKTØR, PH.D. M.D., NSGENE: .......................................................................................................94 MOUSTAPHA KASSEM, AFDELINGSLÆGE, DR.MED., PH.D., ODENSE UNIVERSITETSHOSPITAL:..............................................95 PRÆSENTATION AF OPLÆGSHOLDERE..................................................................................................................109 METTE KIRSTINE AGGER..............................................................................................................................................109 SVEND ANDERSEN.......................................................................................................................................................109 OLE FÆRGEMAN..........................................................................................................................................................109 METTE HARTLEV.........................................................................................................................................................110 OLE J. HARTLING.........................................................................................................................................................110 KERSTIN HOFFMANN ..................................................................................................................................................110 PETER HOKLAND.........................................................................................................................................................110 STEN EIRIK WÆLGAARD JACOBSEN...............................................................................................................................111 JENS-OTTO SKOVGAARD JEPPESEN ...............................................................................................................................111 MOUSTAPHA KASSEM .................................................................................................................................................111 LENE KOCH.................................................................................................................................................................111 OLE D. MADSEN .........................................................................................................................................................111 JESPER NORUS.............................................................................................................................................................112 JENS ZIMMER RASMUSSEN...........................................................................................................................................112 MADS KROGSGAARD THOMSEN...................................................................................................................................112 LARS U. WAHLBERG....................................................................................................................................................113 PETER ØHRSTRØM .......................................................................................................................................................113 ABSTRACT OF PRESENTATION................................................................................................................................114 AF STEN EIRIK JACOBSEN, PROFESSOR M.D., PH.D., DEPT OF STEM CELL BIOLOGY, LUND UNIVERSITETSHOSPITAL FORSKELLIGE KILDER TIL STAMCELLER – FORSKELLIGE POLITISKE OG ETISKE OVERVEJELSER.................115 AF PETER HOKLAND, PROFESSOR, OVERLÆGE, DR. MED., ÅRHUS AMTSSYGEHUS DET MENNESKELIGE EMBRYONS ETISK-RETLIGE STATUS – OM DET SÅKALDTE ’GRADUALISTISKE’ SYN ...........................................................................................................................................120 AF SVEND ANDERSEN, PROFESSOR DR.THEOL., CENTER FOR BIOETIK, AARHUS UNIVERSITET FOSTERANLÆGGETS STATUS - ET SPØRGSMÅL OM RESPEKT ...........................................................................124 AF LANDSSEKRETÆR, DR.MED., KERSTIN HOFFMANN, RETTEN TIL LIV. EMBRYONALE STAMCELLER OG LOVGIVNING ....................................................................................................127 AF METTE HARTLEV, LEKTOR PH.D., NÆSTFORMAND FOR DET ETISKE RÅD DET FORSKNINGSMÆSSIGE POTENTIALE I DANMARK .....................................................................................134 AF JENS ZIMMER RASMUSSEN, PROFESSOR DR. MED., DANSK CENTER FOR STAMCELLEFORSKNING
<strong>Embryonale</strong> stamceller – høring om anvendelse af stamceller i forskning og behandling 23. januar 2003 DET FORSKNINGSMÆSSIGE POTENTIALE.............................................................................................................138 AF OLE D. MADSEN, PH.D., FORSKNINGSCHEF, HAGEDORN RESEARCH INSTITUTE EMBRYONALE STAMCELLER: DE ERHVERVSMÆSSIGE PERSPEKTIVER ...........................................................142 AF MADS KROGSGAARD THOMSEN, PROFESSOR DR.MED.VET., KONCERNDIREKTØR FOR FORSKNING & UDVIKLING, NOVO NORDISK A/S DE ERHVERVSMÆSSIGE PERSPEKTIVER................................................................................................................146 AF METTE KIRSTINE AGGER, ADMINISTRERENDE DIREKTØR 7TM PHARMA, FORENINGEN AF BIOTEKNOLOGISKE INDUSTRIER I DANMARK DEN ERHVERVSMÆSSIGE UDFORDRING I FORBINDELSE MED UDVIKLING OG ANVENDELSE AF STAMCELLER – HVAD KAN VI LÆRE FRA ANDRE BIOTEKNOLOGISKE OMRÅDER? ......................................149 AF JESPER NORUS, LEKTOR, INSTITUTLEDER, INSTITUT FOR ORGANISATION OG ARBEJDSSOCIOLOGI, HANDELSHØJSKOLEN I KØBENHAVN SUNDHEDSMÆSSIGE PERSPEKTIVER ....................................................................................................................152 AF OLE FÆRGEMAN, PROFESSOR, DR.MED., DEN CENTRALE VIDENSKABSETISKE KOMITÉ, ÅRHUS UNIVERSITETSHOSPITAL SUNDHEDSMÆSSIGE PERSPEKTIVER AF STAMCELLEFORSKNINGEN .............................................................155 AF JENS-OTTO S. JEPPESEN, OMRÅDEDIREKTØR, ODENSE UNIVERSITETSHOSPITAL VALG I ET DILEMMA .................................................................................................................................................159 AF OLE J. HARTLING, OVERLÆGE, DR.MED., FORMAND FOR DET ETISKE RÅD ETISKE PROBLEMER IFM. UDNYTTELSEN AF FOSTERANLÆG TIL FORSKNING OG UDVIKLING AF NY SYGDOMSBEHANDLING ..........................................................................................................................................163 AF PETER ØHRSTRØM, PROFESSOR, DR. SCIENT., MEDLEM AF DET ETISKE RÅD OM STAMCELLEFORSKNING ...................................................................................................................................166 AF LENE KOCH, LEKTOR, DR. PHIL., INSTITUT FOR FOLKESUNDHEDSVIDENSKAB, KØBENHAVNS UNIVERSITET FORSKNING I HUMANE EMBRYONALE STAMCELLER: ER DET EN TRUSSEL FOR VORT SAMFUND? ..........169 AF MOUSTAPHA KASSEM, AFDELINGSLÆGE, DR.MED., PH.D., ODENSE UNIVERSITETSHOSPITAL PROGRAM...................................................................................................................................................................172 POLITISK SPØRGEPANEL ..........................................................................................................................................176 PLANLÆGNINGSGRUPPEN ......................................................................................................................................177 DELTAGERLISTE.........................................................................................................................................................178 BIOSAM - SAMARBEJDE OM BIOTEKNOLOGI.......................................................................................................183 BILAG 1: ......................................................................................................................................................................185 HUMAN STEM CELL RESEARCH: SCIENTIFIC UNCERTAINTIES AND ETHICAL DILEMMAS..........................185 AF EUROPEAN SCIENCE FOUNDATION BILAG 2: UDTALELSE FRA LANDSFORENINGEN FOR UFRIVILLIGT BARNLØSE ..............................................186 TOMAS THERKILDSEN, FORMAND, LANDSFORENINGEN FOR UFRIVILLIGT BARNLØSE
Page 1 and 2: Embryonale stamceller - høring om
Page 3: Embryonale stamceller - høring om
Page 55 and 56:
Embryonale stamceller - høring om
Page 57 and 58:
Page 59 and 60:
Page 61 and 62:
Page 63 and 64:
Page 65 and 66:
Page 67 and 68:
Page 69 and 70:
Page 71 and 72:
Page 73 and 74:
Page 75 and 76:
Page 77 and 78:
Page 79 and 80:
Page 81 and 82:
Page 83 and 84:
Page 85 and 86:
Page 87 and 88:
Page 89 and 90:
Page 91 and 92:
Page 93 and 94:
Page 95 and 96:
Page 97 and 98:
Page 99 and 100:
Page 101 and 102:
Page 103 and 104:
Page 105 and 106:
Page 107 and 108:
Page 109 and 110:
Page 111 and 112:
Page 113 and 114:
Page 115 and 116:
Page 117 and 118:
Page 119 and 120:
Page 121 and 122:
Page 123 and 124:
Page 125 and 126:
Page 127 and 128:
Page 129 and 130:
Page 131 and 132:
Page 133 and 134:
Page 135 and 136:
Page 137 and 138:
Page 139 and 140:
Page 141 and 142:
Page 143 and 144:
Page 145 and 146:
Page 147 and 148:
Page 149 and 150:
Page 151 and 152:
Page 153 and 154:
Page 155 and 156:
Page 157 and 158:
Page 159 and 160:
Page 161 and 162:
Page 163 and 164:
Page 165 and 166:
Page 167 and 168:
Page 169 and 170:
Page 171 and 172:
Page 173 and 174:
Page 175 and 176:
Page 177 and 178:
Page 179 and 180:
Page 181 and 182:
Page 183 and 184:
Page 185 and 186:
Page 187 and 188:
Page 189 and 190:
Page 191 and 192:
Contents Introduction p. 1 The biol
Page 193 and 194:
Hence, to get embryos that are surp
Page 195 and 196:
4. There are major differences in t
Page 197 and 198:
Country Reproductive cloning preven
Page 199:
show all

Rapport: "Embryonale stamceller". - Teknologirådet

Create successful ePaper yourself

Delete template?

Save as template?